Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurologic Disorder Treatment Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Anticholinergic
1.2.3 Antiepileptic
1.2.4 Antipsychotic
1.2.5 Hypnotic and Sedative
1.2.6 Analgesics
1.2.7 Antihypertensive
1.2.8 Anticoagulants
1.2.9 Others
1.3 Market by Application
1.3.1 Global Neurologic Disorder Treatment Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Epilepsy
1.3.3 Alzheimer’s Disease
1.3.4 Parkinson's Disease
1.3.5 Multiple Sclerosis
1.3.6 Cerebrovascular Disease
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurologic Disorder Treatment Drug Market Perspective (2018-2034)
2.2 Global Neurologic Disorder Treatment Drug Growth Trends by Region
2.2.1 Neurologic Disorder Treatment Drug Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Neurologic Disorder Treatment Drug Historic Market Size by Region (2018-2024)
2.2.3 Neurologic Disorder Treatment Drug Forecasted Market Size by Region (2024-2034)
2.3 Neurologic Disorder Treatment Drug Market Dynamics
2.3.1 Neurologic Disorder Treatment Drug Industry Trends
2.3.2 Neurologic Disorder Treatment Drug Market Drivers
2.3.3 Neurologic Disorder Treatment Drug Market Challenges
2.3.4 Neurologic Disorder Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Neurologic Disorder Treatment Drug by Players
3.1.1 Global Neurologic Disorder Treatment Drug Revenue by Players (2018-2024)
3.1.2 Global Neurologic Disorder Treatment Drug Revenue Market Share by Players (2018-2024)
3.2 Global Neurologic Disorder Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Neurologic Disorder Treatment Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Neurologic Disorder Treatment Drug Market Concentration Ratio
3.4.1 Global Neurologic Disorder Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurologic Disorder Treatment Drug Revenue in 2022
3.5 Global Key Players of Neurologic Disorder Treatment Drug Head office and Area Served
3.6 Global Key Players of Neurologic Disorder Treatment Drug, Product and Application
3.7 Global Key Players of Neurologic Disorder Treatment Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurologic Disorder Treatment Drug Breakdown Data by Type
4.1 Global Neurologic Disorder Treatment Drug Historic Market Size by Type (2018-2024)
4.2 Global Neurologic Disorder Treatment Drug Forecasted Market Size by Type (2024-2034)
5 Neurologic Disorder Treatment Drug Breakdown Data by Application
5.1 Global Neurologic Disorder Treatment Drug Historic Market Size by Application (2018-2024)
5.2 Global Neurologic Disorder Treatment Drug Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Neurologic Disorder Treatment Drug Market Size (2018-2034)
6.2 North America Neurologic Disorder Treatment Drug Market Size by Type
6.2.1 North America Neurologic Disorder Treatment Drug Market Size by Type (2018-2024)
6.2.2 North America Neurologic Disorder Treatment Drug Market Size by Type (2024-2034)
6.2.3 North America Neurologic Disorder Treatment Drug Market Share by Type (2018-2034)
6.3 North America Neurologic Disorder Treatment Drug Market Size by Application
6.3.1 North America Neurologic Disorder Treatment Drug Market Size by Application (2018-2024)
6.3.2 North America Neurologic Disorder Treatment Drug Market Size by Application (2024-2034)
6.3.3 North America Neurologic Disorder Treatment Drug Market Share by Application (2018-2034)
6.4 North America Neurologic Disorder Treatment Drug Market Size by Country
6.4.1 North America Neurologic Disorder Treatment Drug Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Neurologic Disorder Treatment Drug Market Size by Country (2018-2024)
6.4.3 North America Neurologic Disorder Treatment Drug Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Neurologic Disorder Treatment Drug Market Size (2018-2034)
7.2 Europe Neurologic Disorder Treatment Drug Market Size by Type
7.2.1 Europe Neurologic Disorder Treatment Drug Market Size by Type (2018-2024)
7.2.2 Europe Neurologic Disorder Treatment Drug Market Size by Type (2024-2034)
7.2.3 Europe Neurologic Disorder Treatment Drug Market Share by Type (2018-2034)
7.3 Europe Neurologic Disorder Treatment Drug Market Size by Application
7.3.1 Europe Neurologic Disorder Treatment Drug Market Size by Application (2018-2024)
7.3.2 Europe Neurologic Disorder Treatment Drug Market Size by Application (2024-2034)
7.3.3 Europe Neurologic Disorder Treatment Drug Market Share by Application (2018-2034)
7.4 Europe Neurologic Disorder Treatment Drug Market Size by Country
7.4.1 Europe Neurologic Disorder Treatment Drug Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Neurologic Disorder Treatment Drug Market Size by Country (2018-2024)
7.4.3 Europe Neurologic Disorder Treatment Drug Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Neurologic Disorder Treatment Drug Market Size (2018-2034)
8.2 China Neurologic Disorder Treatment Drug Market Size by Type
8.2.1 China Neurologic Disorder Treatment Drug Market Size by Type (2018-2024)
8.2.2 China Neurologic Disorder Treatment Drug Market Size by Type (2024-2034)
8.2.3 China Neurologic Disorder Treatment Drug Market Share by Type (2018-2034)
8.3 China Neurologic Disorder Treatment Drug Market Size by Application
8.3.1 China Neurologic Disorder Treatment Drug Market Size by Application (2018-2024)
8.3.2 China Neurologic Disorder Treatment Drug Market Size by Application (2024-2034)
8.3.3 China Neurologic Disorder Treatment Drug Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Neurologic Disorder Treatment Drug Market Size (2018-2034)
9.2 Asia Neurologic Disorder Treatment Drug Market Size by Type
9.2.1 Asia Neurologic Disorder Treatment Drug Market Size by Type (2018-2024)
9.2.2 Asia Neurologic Disorder Treatment Drug Market Size by Type (2024-2034)
9.2.3 Asia Neurologic Disorder Treatment Drug Market Share by Type (2018-2034)
9.3 Asia Neurologic Disorder Treatment Drug Market Size by Application
9.3.1 Asia Neurologic Disorder Treatment Drug Market Size by Application (2018-2024)
9.3.2 Asia Neurologic Disorder Treatment Drug Market Size by Application (2024-2034)
9.3.3 Asia Neurologic Disorder Treatment Drug Market Share by Application (2018-2034)
9.4 Asia Neurologic Disorder Treatment Drug Market Size by Region
9.4.1 Asia Neurologic Disorder Treatment Drug Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Neurologic Disorder Treatment Drug Market Size by Region (2018-2024)
9.4.3 Asia Neurologic Disorder Treatment Drug Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Neurologic Disorder Treatment Drug Introduction
11.1.4 AbbVie Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.1.5 AbbVie Recent Developments
11.2 Acadia Pharmaceuticals
11.2.1 Acadia Pharmaceuticals Company Details
11.2.2 Acadia Pharmaceuticals Business Overview
11.2.3 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Introduction
11.2.4 Acadia Pharmaceuticals Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.2.5 Acadia Pharmaceuticals Recent Developments
11.3 Acorda Therapeutics Biotechnology
11.3.1 Acorda Therapeutics Biotechnology Company Details
11.3.2 Acorda Therapeutics Biotechnology Business Overview
11.3.3 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Introduction
11.3.4 Acorda Therapeutics Biotechnology Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.3.5 Acorda Therapeutics Biotechnology Recent Developments
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Neurologic Disorder Treatment Drug Introduction
11.4.4 Bayer Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.4.5 Bayer Recent Developments
11.5 Biogen
11.5.1 Biogen Company Details
11.5.2 Biogen Business Overview
11.5.3 Biogen Neurologic Disorder Treatment Drug Introduction
11.5.4 Biogen Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.5.5 Biogen Recent Developments
11.6 CSK
11.6.1 CSK Company Details
11.6.2 CSK Business Overview
11.6.3 CSK Neurologic Disorder Treatment Drug Introduction
11.6.4 CSK Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.6.5 CSK Recent Developments
11.7 Eisai
11.7.1 Eisai Company Details
11.7.2 Eisai Business Overview
11.7.3 Eisai Neurologic Disorder Treatment Drug Introduction
11.7.4 Eisai Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.7.5 Eisai Recent Developments
11.8 F. Hoffmann La Roche
11.8.1 F. Hoffmann La Roche Company Details
11.8.2 F. Hoffmann La Roche Business Overview
11.8.3 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Introduction
11.8.4 F. Hoffmann La Roche Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.8.5 F. Hoffmann La Roche Recent Developments
11.9 H Lundbeck
11.9.1 H Lundbeck Company Details
11.9.2 H Lundbeck Business Overview
11.9.3 H Lundbeck Neurologic Disorder Treatment Drug Introduction
11.9.4 H Lundbeck Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.9.5 H Lundbeck Recent Developments
11.10 Johnson and Johnson
11.10.1 Johnson and Johnson Company Details
11.10.2 Johnson and Johnson Business Overview
11.10.3 Johnson and Johnson Neurologic Disorder Treatment Drug Introduction
11.10.4 Johnson and Johnson Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.10.5 Johnson and Johnson Recent Developments
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Neurologic Disorder Treatment Drug Introduction
11.11.4 Merck Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.11.5 Merck Recent Developments
11.12 Novartis
11.12.1 Novartis Company Details
11.12.2 Novartis Business Overview
11.12.3 Novartis Neurologic Disorder Treatment Drug Introduction
11.12.4 Novartis Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.12.5 Novartis Recent Developments
11.13 Otsuka Pharmaceutical
11.13.1 Otsuka Pharmaceutical Company Details
11.13.2 Otsuka Pharmaceutical Business Overview
11.13.3 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Introduction
11.13.4 Otsuka Pharmaceutical Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.13.5 Otsuka Pharmaceutical Recent Developments
11.14 Pfizer
11.14.1 Pfizer Company Details
11.14.2 Pfizer Business Overview
11.14.3 Pfizer Neurologic Disorder Treatment Drug Introduction
11.14.4 Pfizer Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.14.5 Pfizer Recent Developments
11.15 Sanofi
11.15.1 Sanofi Company Details
11.15.2 Sanofi Business Overview
11.15.3 Sanofi Neurologic Disorder Treatment Drug Introduction
11.15.4 Sanofi Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.15.5 Sanofi Recent Developments
11.16 Takeda Pharmaceutical
11.16.1 Takeda Pharmaceutical Company Details
11.16.2 Takeda Pharmaceutical Business Overview
11.16.3 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Introduction
11.16.4 Takeda Pharmaceutical Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.16.5 Takeda Pharmaceutical Recent Developments
11.17 Teva Pharmaceutical Industries
11.17.1 Teva Pharmaceutical Industries Company Details
11.17.2 Teva Pharmaceutical Industries Business Overview
11.17.3 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Introduction
11.17.4 Teva Pharmaceutical Industries Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.17.5 Teva Pharmaceutical Industries Recent Developments
11.18 UCB
11.18.1 UCB Company Details
11.18.2 UCB Business Overview
11.18.3 UCB Neurologic Disorder Treatment Drug Introduction
11.18.4 UCB Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.18.5 UCB Recent Developments
11.19 USWM
11.19.1 USWM Company Details
11.19.2 USWM Business Overview
11.19.3 USWM Neurologic Disorder Treatment Drug Introduction
11.19.4 USWM Revenue in Neurologic Disorder Treatment Drug Business (2018-2024)
11.19.5 USWM Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Neurologic Disorder Treatment Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Anticholinergic
Table 3. Key Players of Antiepileptic
Table 4. Key Players of Antipsychotic
Table 5. Key Players of Hypnotic and Sedative
Table 6. Key Players of Analgesics
Table 7. Key Players of Antihypertensive
Table 8. Key Players of Anticoagulants
Table 9. Key Players of Others
Table 10. Global Neurologic Disorder Treatment Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 11. Global Neurologic Disorder Treatment Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 12. Global Neurologic Disorder Treatment Drug Market Size by Region (2018-2024) & (US$ Million)
Table 13. Global Neurologic Disorder Treatment Drug Market Share by Region (2018-2024)
Table 14. Global Neurologic Disorder Treatment Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 15. Global Neurologic Disorder Treatment Drug Market Share by Region (2024-2034)
Table 16. Neurologic Disorder Treatment Drug Market Trends
Table 17. Neurologic Disorder Treatment Drug Market Drivers
Table 18. Neurologic Disorder Treatment Drug Market Challenges
Table 19. Neurologic Disorder Treatment Drug Market Restraints
Table 20. Global Neurologic Disorder Treatment Drug Revenue by Players (2018-2024) & (US$ Million)
Table 21. Global Neurologic Disorder Treatment Drug Revenue Share by Players (2018-2024)
Table 22. Global Top Neurologic Disorder Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurologic Disorder Treatment Drug as of 2022)
Table 23. Global Neurologic Disorder Treatment Drug Industry Ranking 2021 VS 2022 VS 2024
Table 24. Global 5 Largest Players Market Share by Neurologic Disorder Treatment Drug Revenue (CR5 and HHI) & (2018-2024)
Table 25. Global Key Players of Neurologic Disorder Treatment Drug, Headquarters and Area Served
Table 26. Global Key Players of Neurologic Disorder Treatment Drug, Product and Application
Table 27. Global Key Players of Neurologic Disorder Treatment Drug, Product and Application
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Neurologic Disorder Treatment Drug Market Size by Type (2018-2024) & (US$ Million)
Table 30. Global Neurologic Disorder Treatment Drug Revenue Market Share by Type (2018-2024)
Table 31. Global Neurologic Disorder Treatment Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 32. Global Neurologic Disorder Treatment Drug Revenue Market Share by Type (2024-2034)
Table 33. Global Neurologic Disorder Treatment Drug Market Size by Application (2018-2024) & (US$ Million)
Table 34. Global Neurologic Disorder Treatment Drug Revenue Share by Application (2018-2024)
Table 35. Global Neurologic Disorder Treatment Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 36. Global Neurologic Disorder Treatment Drug Revenue Share by Application (2024-2034)
Table 37. North America Neurologic Disorder Treatment Drug Market Size by Type (2018-2024) & (US$ Million)
Table 38. North America Neurologic Disorder Treatment Drug Market Size by Type (2024-2034) & (US$ Million)
Table 39. North America Neurologic Disorder Treatment Drug Market Size by Application (2018-2024) & (US$ Million)
Table 40. North America Neurologic Disorder Treatment Drug Market Size by Application (2024-2034) & (US$ Million)
Table 41. North America Neurologic Disorder Treatment Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 42. North America Neurologic Disorder Treatment Drug Market Size by Country (2018-2024) & (US$ Million)
Table 43. North America Neurologic Disorder Treatment Drug Market Size by Country (2024-2034) & (US$ Million)
Table 44. Europe Neurologic Disorder Treatment Drug Market Size by Type (2018-2024) & (US$ Million)
Table 45. Europe Neurologic Disorder Treatment Drug Market Size by Type (2024-2034) & (US$ Million)
Table 46. Europe Neurologic Disorder Treatment Drug Market Size by Application (2018-2024) & (US$ Million)
Table 47. Europe Neurologic Disorder Treatment Drug Market Size by Application (2024-2034) & (US$ Million)
Table 48. Europe Neurologic Disorder Treatment Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 49. Europe Neurologic Disorder Treatment Drug Market Size by Country (2018-2024) & (US$ Million)
Table 50. Europe Neurologic Disorder Treatment Drug Market Size by Country (2024-2034) & (US$ Million)
Table 51. China Neurologic Disorder Treatment Drug Market Size by Type (2018-2024) & (US$ Million)
Table 52. China Neurologic Disorder Treatment Drug Market Size by Type (2024-2034) & (US$ Million)
Table 53. China Neurologic Disorder Treatment Drug Market Size by Application (2018-2024) & (US$ Million)
Table 54. China Neurologic Disorder Treatment Drug Market Size by Application (2024-2034) & (US$ Million)
Table 55. Asia Neurologic Disorder Treatment Drug Market Size by Type (2018-2024) & (US$ Million)
Table 56. Asia Neurologic Disorder Treatment Drug Market Size by Type (2024-2034) & (US$ Million)
Table 57. Asia Neurologic Disorder Treatment Drug Market Size by Application (2018-2024) & (US$ Million)
Table 58. Asia Neurologic Disorder Treatment Drug Market Size by Application (2024-2034) & (US$ Million)
Table 59. Asia Neurologic Disorder Treatment Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 60. Asia Neurologic Disorder Treatment Drug Market Size by Region (2018-2024) & (US$ Million)
Table 61. Asia Neurologic Disorder Treatment Drug Market Size by Region (2024-2034) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Type (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Type (2024-2034) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Application (2018-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Application (2024-2034) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 67. Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Country (2018-2024) & (US$ Million)
Table 68. Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size by Country (2024-2034) & (US$ Million)
Table 69. AbbVie Company Details
Table 70. AbbVie Business Overview
Table 71. AbbVie Neurologic Disorder Treatment Drug Product
Table 72. AbbVie Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 73. AbbVie Recent Developments
Table 74. Acadia Pharmaceuticals Company Details
Table 75. Acadia Pharmaceuticals Business Overview
Table 76. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Product
Table 77. Acadia Pharmaceuticals Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 78. Acadia Pharmaceuticals Recent Developments
Table 79. Acorda Therapeutics Biotechnology Company Details
Table 80. Acorda Therapeutics Biotechnology Business Overview
Table 81. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Product
Table 82. Acorda Therapeutics Biotechnology Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 83. Acorda Therapeutics Biotechnology Recent Developments
Table 84. Bayer Company Details
Table 85. Bayer Business Overview
Table 86. Bayer Neurologic Disorder Treatment Drug Product
Table 87. Bayer Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 88. Bayer Recent Developments
Table 89. Biogen Company Details
Table 90. Biogen Business Overview
Table 91. Biogen Neurologic Disorder Treatment Drug Product
Table 92. Biogen Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 93. Biogen Recent Developments
Table 94. CSK Company Details
Table 95. CSK Business Overview
Table 96. CSK Neurologic Disorder Treatment Drug Product
Table 97. CSK Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 98. CSK Recent Developments
Table 99. Eisai Company Details
Table 100. Eisai Business Overview
Table 101. Eisai Neurologic Disorder Treatment Drug Product
Table 102. Eisai Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 103. Eisai Recent Developments
Table 104. F. Hoffmann La Roche Company Details
Table 105. F. Hoffmann La Roche Business Overview
Table 106. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Product
Table 107. F. Hoffmann La Roche Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 108. F. Hoffmann La Roche Recent Developments
Table 109. H Lundbeck Company Details
Table 110. H Lundbeck Business Overview
Table 111. H Lundbeck Neurologic Disorder Treatment Drug Product
Table 112. H Lundbeck Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 113. H Lundbeck Recent Developments
Table 114. Johnson and Johnson Company Details
Table 115. Johnson and Johnson Business Overview
Table 116. Johnson and Johnson Neurologic Disorder Treatment Drug Product
Table 117. Johnson and Johnson Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 118. Johnson and Johnson Recent Developments
Table 119. Merck Company Details
Table 120. Merck Business Overview
Table 121. Merck Neurologic Disorder Treatment Drug Product
Table 122. Merck Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 123. Merck Recent Developments
Table 124. Novartis Company Details
Table 125. Novartis Business Overview
Table 126. Novartis Neurologic Disorder Treatment Drug Product
Table 127. Novartis Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 128. Novartis Recent Developments
Table 129. Otsuka Pharmaceutical Company Details
Table 130. Otsuka Pharmaceutical Business Overview
Table 131. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Product
Table 132. Otsuka Pharmaceutical Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 133. Otsuka Pharmaceutical Recent Developments
Table 134. Pfizer Company Details
Table 135. Pfizer Business Overview
Table 136. Pfizer Neurologic Disorder Treatment Drug Product
Table 137. Pfizer Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 138. Pfizer Recent Developments
Table 139. Sanofi Company Details
Table 140. Sanofi Business Overview
Table 141. Sanofi Neurologic Disorder Treatment Drug Product
Table 142. Sanofi Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 143. Sanofi Recent Developments
Table 144. Takeda Pharmaceutical Company Details
Table 145. Takeda Pharmaceutical Business Overview
Table 146. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Product
Table 147. Takeda Pharmaceutical Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 148. Takeda Pharmaceutical Recent Developments
Table 149. Teva Pharmaceutical Industries Company Details
Table 150. Teva Pharmaceutical Industries Business Overview
Table 151. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Product
Table 152. Teva Pharmaceutical Industries Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 153. Teva Pharmaceutical Industries Recent Developments
Table 154. UCB Company Details
Table 155. UCB Business Overview
Table 156. UCB Neurologic Disorder Treatment Drug Product
Table 157. UCB Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 158. UCB Recent Developments
Table 159. USWM Company Details
Table 160. USWM Business Overview
Table 161. USWM Neurologic Disorder Treatment Drug Product
Table 162. USWM Revenue in Neurologic Disorder Treatment Drug Business (2018-2024) & (US$ Million)
Table 163. USWM Recent Developments
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurologic Disorder Treatment Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Neurologic Disorder Treatment Drug Market Share by Type: 2022 VS 2034
Figure 3. Anticholinergic Features
Figure 4. Antiepileptic Features
Figure 5. Antipsychotic Features
Figure 6. Hypnotic and Sedative Features
Figure 7. Analgesics Features
Figure 8. Antihypertensive Features
Figure 9. Anticoagulants Features
Figure 10. Others Features
Figure 11. Global Neurologic Disorder Treatment Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 12. Global Neurologic Disorder Treatment Drug Market Share by Application: 2022 VS 2034
Figure 13. Epilepsy Case Studies
Figure 14. Alzheimer’s Disease Case Studies
Figure 15. Parkinson's Disease Case Studies
Figure 16. Multiple Sclerosis Case Studies
Figure 17. Cerebrovascular Disease Case Studies
Figure 18. Others Case Studies
Figure 19. Neurologic Disorder Treatment Drug Report Years Considered
Figure 20. Global Neurologic Disorder Treatment Drug Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 21. Global Neurologic Disorder Treatment Drug Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 22. Global Neurologic Disorder Treatment Drug Market Share by Region: 2022 VS 2034
Figure 23. Global Neurologic Disorder Treatment Drug Market Share by Players in 2022
Figure 24. Global Top Neurologic Disorder Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurologic Disorder Treatment Drug as of 2022)
Figure 25. The Top 10 and 5 Players Market Share by Neurologic Disorder Treatment Drug Revenue in 2022
Figure 26. North America Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. North America Neurologic Disorder Treatment Drug Market Share by Type (2018-2034)
Figure 28. North America Neurologic Disorder Treatment Drug Market Share by Application (2018-2034)
Figure 29. North America Neurologic Disorder Treatment Drug Market Share by Country (2018-2034)
Figure 30. United States Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Canada Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Europe Neurologic Disorder Treatment Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 33. Europe Neurologic Disorder Treatment Drug Market Share by Type (2018-2034)
Figure 34. Europe Neurologic Disorder Treatment Drug Market Share by Application (2018-2034)
Figure 35. Europe Neurologic Disorder Treatment Drug Market Share by Country (2018-2034)
Figure 36. Germany Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. France Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. U.K. Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Italy Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Russia Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Nordic Countries Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. China Neurologic Disorder Treatment Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 43. China Neurologic Disorder Treatment Drug Market Share by Type (2018-2034)
Figure 44. China Neurologic Disorder Treatment Drug Market Share by Application (2018-2034)
Figure 45. Asia Neurologic Disorder Treatment Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 46. Asia Neurologic Disorder Treatment Drug Market Share by Type (2018-2034)
Figure 47. Asia Neurologic Disorder Treatment Drug Market Share by Application (2018-2034)
Figure 48. Asia Neurologic Disorder Treatment Drug Market Share by Region (2018-2034)
Figure 49. Japan Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 50. South Korea Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 51. China Taiwan Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Southeast Asia Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. India Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Australia Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 56. Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Share by Type (2018-2034)
Figure 57. Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Share by Application (2018-2034)
Figure 58. Middle East, Africa, and Latin America Neurologic Disorder Treatment Drug Market Share by Country (2018-2034)
Figure 59. Brazil Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 60. Mexico Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 61. Turkey Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 62. Saudi Arabia Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 63. Israel Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 64. GCC Countries Neurologic Disorder Treatment Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 65. AbbVie Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 66. Acadia Pharmaceuticals Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 67. Acorda Therapeutics Biotechnology Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 68. Bayer Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 69. Biogen Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 70. CSK Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 71. Eisai Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 72. F. Hoffmann La Roche Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 73. H Lundbeck Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 74. Johnson and Johnson Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 75. Merck Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 76. Novartis Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 77. Otsuka Pharmaceutical Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 78. Pfizer Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 79. Sanofi Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 80. Takeda Pharmaceutical Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 81. Teva Pharmaceutical Industries Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 82. UCB Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 83. USWM Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2018-2024)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed